Cargando…
New Conformations of Acylation Adducts of Inhibitors of β-Lactamase from Mycobacterium tuberculosis
[Image: see text] Mycobacterium tuberculosis (Mtb), the main causative agent of tuberculosis (TB), is naturally resistant to β-lactam antibiotics due to the production of the extended spectrum β-lactamase BlaC. β-Lactam/β-lactamase inhibitor combination therapies can circumvent the BlaC-mediated res...
Autores principales: | Tassoni, Raffaella, Blok, Anneloes, Pannu, Navraj S., Ubbink, Marcellus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383187/ https://www.ncbi.nlm.nih.gov/pubmed/30632739 http://dx.doi.org/10.1021/acs.biochem.8b01085 |
Ejemplares similares
-
Phosphate Promotes the Recovery of Mycobacterium
tuberculosis β-Lactamase from Clavulanic Acid
Inhibition
por: Elings, Wouter, et al.
Publicado: (2017) -
The G132S Mutation Enhances the Resistance of Mycobacterium tuberculosis β-Lactamase against
Sulbactam
por: van Alen, Ilona, et al.
Publicado: (2021) -
Mycobacterium tuberculosis β-lactamase variant reduces sensitivity to ampicillin/avibactam in a zebrafish-Mycobacterium marinum model of tuberculosis
por: van Alen, Ilona, et al.
Publicado: (2023) -
Two β-Lactamase Variants with Reduced Clavulanic Acid Inhibition Display Different Millisecond Dynamics
por: Elings, Wouter, et al.
Publicado: (2021) -
The roles of highly conserved, non‐catalytic residues in class A β‐lactamases
por: Chikunova, Aleksandra, et al.
Publicado: (2022)